SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...
Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
Breakthrough Therapy Designation is intended to expedite the development and review of medicines that are intended to treat a serious or life-threatening condition and have shown preliminary clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback